Your browser doesn't support javascript.
Pre-pandemic sleep reactivity prospectively predicts distress during the COVID-19 pandemic: The protective effect of insomnia treatment.
Reffi, Anthony N; Drake, Christopher L; Kalmbach, David A; Jovanovic, Tanja; Norrholm, Seth D; Roth, Thomas; Casement, Melynda D; Cheng, Philip.
  • Reffi AN; Sleep Disorders & Research Center, Henry Ford Health System, Detroit, Michigan, USA.
  • Drake CL; Sleep Disorders & Research Center, Henry Ford Health System, Detroit, Michigan, USA.
  • Kalmbach DA; Sleep Disorders & Research Center, Henry Ford Health System, Detroit, Michigan, USA.
  • Jovanovic T; Neuroscience Center for Anxiety, Stress, and Trauma (NeuroCAST), Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Norrholm SD; Neuroscience Center for Anxiety, Stress, and Trauma (NeuroCAST), Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Roth T; Sleep Disorders & Research Center, Henry Ford Health System, Detroit, Michigan, USA.
  • Casement MD; Department of Psychology, University of Oregon, Eugene, Oregon, USA.
  • Cheng P; Sleep Disorders & Research Center, Henry Ford Health System, Detroit, Michigan, USA.
J Sleep Res ; : e13709, 2022 Aug 29.
Article in English | MEDLINE | ID: covidwho-2234797
ABSTRACT
The COVID-19 pandemic is a rare stressor that has precipitated an accompanying mental health crisis. Prospective studies traversing the pandemic's onset can elucidate how pre-existing disease vulnerabilities augured risk for later stress-related morbidity. We examined how pre-pandemic sleep reactivity predicted maladaptive stress reactions and depressive symptoms in response to, and during, the pandemic. This study is a secondary analysis of a randomised controlled trial from 2016 to 2017 comparing digital cognitive behavioural therapy for insomnia (dCBT-I) against sleep education (N = 208). Thus, we also assessed whether dCBT-I moderated the association between pre-pandemic sleep reactivity and pandemic-related distress. Pre-pandemic sleep reactivity was measured at baseline using the Ford Insomnia Response to Stress Test. In April 2020, participants were recontacted to report pandemic-related distress (stress reactions and depression). Controlling for the treatment condition and the degree of COVID-19 impact, higher pre-pandemic sleep reactivity predicted more stress reactions (ß = 0.13, ± 0.07 SE, p = 0.045) and depression (ß = 0.22, ± 0.07 SE, p = 0.001) during the pandemic. Further, the odds of reporting clinically significant stress reactions and depression during the pandemic were over twice as high in those with high pre-pandemic sleep reactivity. Notably, receiving dCBT-I in 2016-2017 mitigated the relationship between pre-pandemic sleep reactivity and later stress reactions (but not depression). Pre-pandemic sleep reactivity predicted psychological distress 3-4 years later during the COVID-19 pandemic, and dCBT-I attenuated its association with stress reactions, specifically. Sleep reactivity may inform prevention and treatment efforts by identifying individuals at risk of impairment following stressful events.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Sleep Res Journal subject: Psychophysiology Year: 2022 Document Type: Article Affiliation country: Jsr.13709

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: J Sleep Res Journal subject: Psychophysiology Year: 2022 Document Type: Article Affiliation country: Jsr.13709